Genexine financials at a glance

+ Portfolio

The revenue of Genexine is reported as 3.87143 billion Won in the fiscal year 2023. The earnings were -967 Won per share in 2023, which was 118.28 lower than 2022. And about -20.37645 billion Won are reported as free cash flow in the financials of Genexine 2023. No dividends were paid to the shareholders of the Genexine stock KOSDAQ:A095700 in the financial year 2023.

₩3.87B

Revenue

₩-,967.00

Earnings Per Share

6.82%

Gross Margin %

₩0.00M

Free Cash Flow

Revenue

3,871.43

Earnings Per Share

-,967.00

Gross Margin %

6.82

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2020	2019	2018	2017	2016	2014
Rev.	Revenue	N/A	₩3.87B	₩473.31M	₩18.54B	₩11.30B	₩12.88B	₩28.45B	₩0.00M	₩16.66B
GM %	Gross Margin %	14.03%	6.82%	69.70%	52.63%	59.27%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	-,208.69%	-,211.13%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	₩-2,821.41	₩-,967.00	₩-,443.00	₩671.54	₩-,595.38	₩-1,288.46	₩-,808.46	₩-1,197.69	₩-,400.77
Div.	Dividends	N/A	₩0.00	₩0.00	₩0.00	₩0.00	₩0.00	₩0.00	₩0.00	₩0.00
PR %	Payout Ratio %	0	0	0	0.00%	-0.00%	0	0	0	0
Sha.	Shares	N/AM	41.45M	32.69M	32.11M	30.89M	20.43M	19.85M	17.79M	14.76M
OCF	Operating Cash Flow	N/A	₩0.00M	₩0.00M	₩-22,690.96M	₩0.00M	₩-20,054.24M	₩-26,104.45M	₩0.00M	₩0.00M
FCF	Free Cash Flow	N/A	₩0.00M	₩0.00M	₩-44,898.73M	₩0.00M	₩-27,930.09M	₩-46,480.90M	₩0.00M	₩0.00M
FCFS	Free Cash Flow Per Share	₩-1,355.63	₩-1,122.45	₩-2,186.84	₩-1,950.67	₩-2,187.20	₩0.00	₩0.00	₩0.00	₩0.00

Genexine financials at a glance

Financials

Discover